232 related articles for article (PubMed ID: 12612190)
1. Cerebral energy metabolism in phenylketonuria: findings by quantitative In vivo 31P MR spectroscopy.
Pietz J; Rupp A; Ebinger F; Rating D; Mayatepek E; Boesch C; Kreis R
Pediatr Res; 2003 Apr; 53(4):654-62. PubMed ID: 12612190
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria.
Leuzzi V; Bianchi MC; Tosetti M; Carducci CL; Carducci CA; Antonozzi I
J Inherit Metab Dis; 2000 Sep; 23(6):563-70. PubMed ID: 11032331
[TBL] [Abstract][Full Text] [Related]
3. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study.
Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K
J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389
[TBL] [Abstract][Full Text] [Related]
4. The dynamics of brain concentrations of phenylalanine and its clinical significance in patients with phenylketonuria determined by in vivo 1H magnetic resonance spectroscopy.
Pietz J; Kreis R; Boesch C; Penzien J; Rating D; Herschkowitz N
Pediatr Res; 1995 Nov; 38(5):657-63. PubMed ID: 8552430
[TBL] [Abstract][Full Text] [Related]
5. Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria.
Pietz J; Kreis R; Rupp A; Mayatepek E; Rating D; Boesch C; Bremer HJ
J Clin Invest; 1999 Apr; 103(8):1169-78. PubMed ID: 10207169
[TBL] [Abstract][Full Text] [Related]
6. Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional
Rijpma A; van der Graaf M; Meulenbroek O; Olde Rikkert MGM; Heerschap A
Neuroimage Clin; 2018; 18():254-261. PubMed ID: 29876246
[TBL] [Abstract][Full Text] [Related]
7. Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria.
Möller HE; Weglage J; Bick U; Wiedermann D; Feldmann R; Ullrich K
Pediatrics; 2003 Dec; 112(6 Pt 2):1580-3. PubMed ID: 14654669
[TBL] [Abstract][Full Text] [Related]
8. Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria.
Rupp A; Kreis R; Zschocke J; Slotboom J; Boesch C; Rating D; Pietz J
J Cereb Blood Flow Metab; 2001 Mar; 21(3):276-84. PubMed ID: 11295882
[TBL] [Abstract][Full Text] [Related]
9. Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria.
Möller HE; Weglage J; Wiedermann D; Ullrich K
J Cereb Blood Flow Metab; 1998 Nov; 18(11):1184-91. PubMed ID: 9809507
[TBL] [Abstract][Full Text] [Related]
10. Future role of large neutral amino acids in transport of phenylalanine into the brain.
Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
[TBL] [Abstract][Full Text] [Related]
11. Defective brain energy metabolism shown by in vivo 31P MR spectroscopy in 28 patients with mitochondrial cytopathies.
Barbiroli B; Montagna P; Martinelli P; Lodi R; Iotti S; Cortelli P; Funicello R; Zaniol P
J Cereb Blood Flow Metab; 1993 May; 13(3):469-74. PubMed ID: 8478405
[TBL] [Abstract][Full Text] [Related]
12. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
[TBL] [Abstract][Full Text] [Related]
13. 1H MR chemical shift imaging detection of phenylalanine in patients suffering from phenylketonuria (PKU).
Sijens PE; Oudkerk M; Reijngoud DJ; Leenders KL; de Valk HW; van Spronsen FJ
Eur Radiol; 2004 Oct; 14(10):1895-900. PubMed ID: 15378255
[TBL] [Abstract][Full Text] [Related]
14. In vivo proton magnetic resonance spectroscopy in phenylketonuria.
Möller HE; Ullrich K; Weglage J
Eur J Pediatr; 2000 Oct; 159 Suppl 2():S121-5. PubMed ID: 11043158
[TBL] [Abstract][Full Text] [Related]
15. The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study.
Leuzzi V; Tosetti M; Montanaro D; Carducci C; Artiola C; Carducci C; Antonozzi I; Burroni M; Carnevale F; Chiarotti F; Popolizio T; Giannatempo GM; D'Alesio V; Scarabino T
J Inherit Metab Dis; 2007 Apr; 30(2):209-16. PubMed ID: 17245558
[TBL] [Abstract][Full Text] [Related]
16. Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment.
Pietz J; Kreis R; Schmidt H; Meyding-Lamadé UK; Rupp A; Boesch C
Radiology; 1996 Nov; 201(2):413-20. PubMed ID: 8888233
[TBL] [Abstract][Full Text] [Related]
17. In vivo measurement of phenylalanine in human brain by proton nuclear magnetic resonance spectroscopy.
Novotny EJ; Avison MJ; Herschkowitz N; Petroff OA; Prichard JW; Seashore MR; Rothman DL
Pediatr Res; 1995 Feb; 37(2):244-9. PubMed ID: 7731764
[TBL] [Abstract][Full Text] [Related]
18. Localised cerebral phosphorus-31 MR spectroscopy in man before and immediately after coronary bypass surgery with hypothermic cardiopulmonary bypass.
Wilson JA; Taylor-Robinson SD; Bryant DJ; Taylor KM; Harris DN
Metab Brain Dis; 1998 Sep; 13(3):191-200. PubMed ID: 9804364
[TBL] [Abstract][Full Text] [Related]
19. Deficit of brain and skeletal muscle bioenergetics and low brain magnesium in juvenile migraine: an in vivo 31P magnetic resonance spectroscopy interictal study.
Lodi R; Montagna P; Soriani S; Iotti S; Arnaldi C; Cortelli P; Pierangeli G; Patuelli A; Zaniol P; Barbiroli B
Pediatr Res; 1997 Dec; 42(6):866-71. PubMed ID: 9396571
[TBL] [Abstract][Full Text] [Related]
20. Bio-energetic impairment in human calf muscle in thyroid disorders: a 31P MRS study.
Khushu S; Rana P; Sekhri T; Sripathy G; Tripathi RP
Magn Reson Imaging; 2010 Jun; 28(5):683-9. PubMed ID: 20332062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
